Spontaneous report from the USA by a consumer of a female with events of JC VIRUS and non-serious TRIED 
HUMIRA WITH NO HELP and TRIED CIMZIA WITH NO HELP with HUMIRA (ADALIMUMAB).  There was no 
reported medical history.
On unknown dates, the patient experienced JC VIRUS, TRIED HUMIRA WITH NO HELP and TRIED CIMZIA 
WITH NO HELP.  REMICADE for six years and worked great for probably the first four years. Then patient tried 
both HUMIRA and CIMZIA with no help. Did TYSABRE and felt amazing, but got the John Cunningham Virus (JC 
virus). So, the patient had to stop before she got Progressive Multifocal Leukoencephalopathy (PML). The patient 
had some bridge therapies while waiting and on the reporting day the new drug was approved, the patient was 
hoping to start within the next month.  REMICADE (INFLIXIMAB), TYSABRE (NATALIZUMAB) and CIMZIA 
(CERTOLIZUMAB PEGOL) were also considered suspect.
The patient was treated with UNKNOWN MEDICATIONS (BRIDGE THERAPIES).
Causality for HUMIRA(ADALIMUMAB)
The reporter's statement of causality for the events of JC VIRUS, TRIED HUMIRA WITH NO HELP and TRIED 
CIMZIA WITH NO HELP was not provided.
Change History
Amendment to data received on 15 Jul 2014 with changes to event information, reporter opinion of causality, 
suspect drug information and narrative description.  The event of "JC VIRUS" is now considered serious.
Version 1 was created to delete the event 'PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)', No
other information added or amended.
PML was captured as an event in error.